WVXU: Lawsuit claims city’s tax break program for homeowners is discriminatory

UC law professor discusses disparate impact claim and the Fair Housing Act

 A group of Black residents in Cincinnati has filed a lawsuit against the city of Cincinnati alleging discrimination in how tax abatements are granted. The suit claims the city is more segregated because of the way tax abatements are handed out. A federal judge tossed out claims of intentional discrimination but is allowing a claim that the policy has a disparate impact on minority homeowners to go forward. Cincinnati Edition’s Michael Monks spoke with Nate Ela PhD, assistant professor of political science and law at the University of Cincinnati College of Law and Dan Horn, an investigative reporter with the Cincinnati Enquirer about the lawsuit. 

Listen to the WVXU interview online.

Learn more about Nate Ela, PhD.

Related Stories

1

Sugar overload killing hearts

November 10, 2025

Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.

2

Is going nuclear the solution to Ohio’s energy costs?

November 10, 2025

The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.

3

App turns smartwatch into detector of structural heart disease

November 10, 2025

An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.